upstaza
ptc therapeutics international limited - eladocagene exuparvovec - aminohappoaineenvaihdunta, synnynnäiset virheet - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
bacibact 500 iu / g + 5 mg / g voide
orion corporation - neomycin sulfate, bacitracin - voide - 500 iu / g + 5 mg / g - neomysiini
bacibact 250 iu / g + 5 mg / g puuteri
orion corporation - neomycin sulfate, bacitracin - puuteri - 250 iu / g + 5 mg / g - neomysiini
bemetson-k voide
orion oyj - betamethasoni 17-valeras,clioquinolum - voide - beetametasoni ja antiseptit
caprilon 500 mg tabletti
takeda oy - tranexamic acid - tabletti - 500 mg - traneksaamihappo
nitrofur-c 75 mg tabletti, kalvopäällysteinen
takeda oy - ascorbic acid, nitrofurantoin - tabletti, kalvopäällysteinen - 75 mg - nitrofurantoiini
fucidin 250 mg tabletti, kalvopäällysteinen
leo pharma a/s - natrii fusidas - tabletti, kalvopäällysteinen - 250 mg - fusidiinihappo
betaserc 8 mg tabletti
viatris oy - betahistine dihydrochloride - tabletti - 8 mg - betahistiini
betaserc 16 mg tabletti
viatris oy - betahistine dihydrochloride - tabletti - 16 mg - betahistiini
nix 1 % shampoo
aco hud nordic ab - permethrin - shampoo - 1 % - permetriini